Coeliac Active Peptides from Gliadin: Large-scale Preparation and Characterization
Overview
Authors
Affiliations
Larger amounts of coeliac active peptides are required for pathogenetic investigations. Therefore, a simplified preparative procedure by means of gel-permeation chromatography and reversed-phase HPLC was developed for the isolation of the peptides B3141-B3146, which are present in peptic tryptic digests of gliadin [this journal (1983) 176:85-94]. The peptides are derived from the N-terminal part of alpha-gliadins and are closely related. The amino acid sequence of B3143 is VPVPQLQPQNPSQQQPQEQVPLVQQQQFPGQQQQFPPQQPYPQPQPFPSQQPYL. B3144 has proline instead of glutamine in position 34. The previously described peptide B3142 [this journal (1984) 179:371-376] corresponds to B3144 except for the missing C-terminal leucine.
Rakhimova M, Esslinger B, Schulze-Krebs A, Hahn E, Schuppan D, Dieterich W J Clin Immunol. 2008; 29(1):29-37.
PMID: 18696220 DOI: 10.1007/s10875-008-9228-x.
Stern M, Knauss M, Stallmach A Dig Dis Sci. 1995; 40(11):2438-45.
PMID: 7587828 DOI: 10.1007/BF02063251.